Navigation Links
University Hospitals Seidman Cancer Center Tests Novel Drug That Makes Brain Tumors Glow Hot Pink

CLEVELAND, Dec. 1, 2011 /PRNewswire/ -- Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital.

"The pain got worse. When we got to the emergency room, I said to Brad 'something is just not right,'" Rek remembers.

After an MRI showed a suspected tumor, Rek was immediately flown to Seidman Cancer Center at University Hospitals (UH) Case Medical Center, where Andrew Sloan, MD, diagnosed her with Stage 4 glioblastoma, the most aggressive form of brain cancer and the most difficult to treat.

"The tumors are comprised of the brain itself. It looks like brain tissue, it sort of feels like brain tissue. It's hard to figure out necessarily where tumor ends and swollen brain tissue begins," says Dr. Sloan, Director of the Brain Tumor and Neuro-Oncology Center and Peter D. Cristal Chair in Neurosurgery at UH Case Medical Center and Associate Professor at Case Western Reserve University School of Medicine.

To help identify the difference between tumors and healthy tissue and improve tumor resection, Dr. Sloan is testing an experimental drug called 5-Aminolevulinic Acid (5-ALA). The drug makes brain tumor cells glow hot pink when illuminated with a special blue light incorporated into his operating microscope.

This novel technique enables surgeons to visualize the edges of the tumor more clearly, allowing them to remove it more completely from the brain. Patients take the drug by mouth prior to surgery and then during their operation, Dr. Sloan uses the blue light to identify and remove tumor cells, a process called fluorescent guided resection (FGR). 

Rek is now one of the volunteers in the research trial.

Compared to normal tissue, high-grade gliomas (or brain tumors) metabolize 5-ALA to a fluorescent compound called protoporphyrin ix, a structure similar to that of chlorophyll found in plants. Tumors that absorb this compound fluoresce (glow) with the blue light. Using a specially modified surgical microscope that contains the blue light enables Dr. Sloan to see the glowing tumor tissue and help guide excision of the tumor.

"If we get out 95 to 99 percent of the tumor, we can almost essentially double the patient's survival," says Dr. Sloan.

Although 5-ALA is routinely used for FGR in Europe, it has not been approved by the FDA in the United States and thus is not widely used.  UH Case Medical Center is one of a handful of hospitals studying the drug in the U.S. for brain tumor surgery.  

Dr. Sloan, lead investigator of the study looking at the effects of varying 5-ALA dose levels, is collaborating with David Dean, PhD, Associate Professor and Director of the Imaging Laboratory in the Department of Neurological Surgery at Case Western Reserve University.

Dr. Dean, an engineer, is working with Dr. Sloan to improve how FGR is performed by precisely measuring protoporphyrin ix fluorescence in tumors using a digital fiber-optic probe during surgery.  Drs. Dean and Sloan believe that the digital probe will be both more sensitive and more precise than the current technique which is based on the surgeon's perception of how "pink" the tumor is.

The study is supported with funds from Dr. Sloan's Peter D. Cristal Chair in Neurosurgery and the Kimble Foundation.

"Nearly 13,000 people are diagnosed each year in the U.S. with malignant gliomas.  Unfortunately, cures are rare and most patients live less than 2 years, so improved treatment options are critical," says Dr. Sloan.

A video about the 5-ALA research and Lisa Rek's story can be viewed at:

About University Hospitals
University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians.  At the core of our health system is University Hospitals Case Medical Center.  The primary affiliate of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. For more information, go to


SOURCE University Hospitals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply Tender
2. Clinicians at the University of Alabama at Birmingham (UAB) Health System First in World to Use "Triggered Imaging" Technology From Varian Medical Systems
3. Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
4. University Hospitals Case Medical Center Researchers Search for Mysteries of Dystonia With Advanced Brain Imaging
5. International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment
6. DMC Harper University Hospital is the First in Michigan to Utilize New Device for Brain Tumor Removal
7. Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland
8. Waters Recognizes the Dr. Ganesh Anand Laboratory at the National University of Singapore as Center of Innovation
9. VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How
10. Cardinal Health Foundation, The Ohio State University Launch New Toolkit to Help Reduce Misuse of Prescription Drugs
11. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):